ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

Avigan maker gets hometown help to secure scarce key ingredient

Toyama Prefecture will fund companies that produce A11 as China halts exports

Fujifilm Toyama Chemical developed the flu drug Avigan, which was approved for use in 2014. (Photo courtesy of Fujifilm Toyama Chemical)

TOYAMA, Japan -- The maker of Avigan is slated to receive local government help in accessing a critical ingredient, a goal in line with Japanese plans to stockpile the flu drug showing promise against the novel coronavirus.

The Fujifilm Holdings unit's home prefecture of Toyama plans to support local companies that make investments to produce the precursor.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more